Skip NavigationSkip to Content
Return Return to Search Results

Nanoparticle therapeutics: a personal perspective

  1. Author:
    McNeil, S. E.

  2. Author Address

    NCI, Nanotechnol Characterizat Lab, Imaging & Nanotechnol Grp, SAIC Frederick Inc, Frederick, MD 21701 USA.;McNeil, SE, NCI, Nanotechnol Characterizat Lab, Imaging & Nanotechnol Grp, SAIC Frederick Inc, Frederick, MD 21701 USA.;ncl@mail.nih.gov
    1. Year: 2009
    2. Date: May-Jun
  2. Journal: Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
    1. 1
    2. 3
    3. Pages: 264-271
  4. Type of Article: Review
  5. ISSN: 1939-5116
  1. Abstract:

    Nanotechnology offers many potential benefits to cancer research through passive and active targeting, increased solubility/bioavailablility, and novel therapies. However, preclinical characterization of nanoparticles is complicated by the variety of materials, their unique surface properties, reactivity, and the task of tracking the individual components of multicomponent, multifunctional nanoparticle therapeutics in in vivo studies. There are also regulatory considerations and scale-up challenges that must be addressed. Despite these hurdles, cancer research has seen appreciable improvements in efficacy and quite a decrease in the toxicity of chemotherapeutics because of 'nanotech' formulations, and several engineered nanoparticle clinical trials are well underway. This article reviews some of the challenges and benefits of nanomedicine for cancer therapeutics and diagnostics. (C) 2009 John Wiley & Sons, Inc. WIREs Nanomed Nanobiotechnol 2009 1 264-271

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1002/wnan.006
  3. View record in Web of Science®
  4. WOS: 000276839500002

Library Notes

  1. Fiscal Year: FY2008-2009
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel